Cargando…

Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc

Our three-dimensional organotypic culture revealed that human histone demethylase (KDM) 4C, a histone lysine demethylase, hindered the acini morphogenesis of RWPE-1 prostate cells, suggesting its potential oncogenic role. Knockdown (KD) of KDM4C suppressed cell proliferation, soft agar colony format...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ching-Yu, Wang, Bi-Juan, Chen, Bo-Chih, Tseng, Jen-Chih, Jiang, Shih Sheng, Tsai, Kelvin K., Shen, Ying-Ying, Yuh, Chiou Hwa, Sie, Zong-Lin, Wang, Wen-Ching, Kung, Hsing-Jien, Chuu, Chih-Pin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896035/ https://www.ncbi.nlm.nih.gov/pubmed/31766290 http://dx.doi.org/10.3390/cancers11111785

Ejemplares similares

Inhibition of KDM4C/c‐Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism
por: Lin, Ching‐Yu, et al.
Publicado: (2022)

Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer
por: Wu, Meng-Jen, et al.
Publicado: (2021)

Targeting the histone demethylase PHF8-mediated PKCα-Src-PTEN axis in HER2-negative gastric cancer
por: Tseng, Lin-Lu, et al.
Publicado: (2020)

Essential Roles of the Histone Demethylase KDM4C in Renal Development and Acute Kidney Injury
por: Pan, Heng-Chih, et al.
Publicado: (2022)

KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis
por: Wu, Meng-Chen, et al.
Publicado: (2019)

Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc
por: Lee, Dong Hoon, et al.
Publicado: (2021)

Substrate- and Cofactor-independent Inhibition of Histone Demethylase KDM4C
por: Leurs, Ulrike, et al.
Publicado: (2014)

Histone Demethylase KDM4C Is Required for Ovarian Cancer Stem Cell Maintenance
por: Chen, Guo-Qing, et al.
Publicado: (2020)

Molecular architecture of the Jumonji C family histone demethylase KDM5B
por: Dorosz, Jerzy, et al.
Publicado: (2019)

Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer
por: Liu, Jai-Shin, et al.
Publicado: (2022)

Histone Demethylase KDM5C Drives Prostate Cancer Progression by Promoting EMT
por: Lemster, Anna-Lena, et al.
Publicado: (2022)

Sexually Dimorphic Alterations in the Transcriptome and Behavior with Loss of Histone Demethylase KDM5C
por: Bonefas, Katherine M., et al.
Publicado: (2023)

Histone Demethylases KDM4A and KDM4C Regulate Differentiation of Embryonic Stem Cells to Endothelial Cells
por: Wu, Liangtang, et al.
Publicado: (2015)

Histone Lysine Demethylases KDM5B and KDM5C Modulate Genome Activation and Stability in Porcine Embryos
por: Glanzner, Werner Giehl, et al.
Publicado: (2020)

SUMO Modification of Histone Demethylase KDM4A in Kaposi’s Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma
por: Yeh, Wayne W., et al.
Publicado: (2022)

KDM5D Histone Demethylase Identifies Platinum-Tolerant Head and Neck Cancer Cells Vulnerable to Mitotic Catastrophe
por: Chen, Tsung-Ming, et al.
Publicado: (2023)

Histone demethylase KDM4C is a functional dependency in JAK2-mutated neoplasms
por: Ernst, Philipp, et al.
Publicado: (2022)

Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor
por: Peng, Daohu, et al.
Publicado: (2021)

The Histone Demethylase KDM5 Is Essential for Larval Growth in Drosophila
por: Drelon, Coralie, et al.
Publicado: (2018)

The nuclear bodies formed by histone demethylase KDM7A
por: Ming, Hui, et al.
Publicado: (2020)

The Activity of JmjC Histone Lysine Demethylase KDM4A is Highly Sensitive to Oxygen Concentrations
por: Hancock, Rebecca L, et al.
Publicado: (2017)

The histone demethylase KDM5C controls female bone mass by promoting energy metabolism in osteoclasts
por: Liu, Huadie, et al.
Publicado: (2023)

The histone demethylase KDM5C controls female bone mass by promoting energy metabolism in osteoclasts
por: Liu, Huadie, et al.
Publicado: (2023)

Knockout of the Histone Demethylase Kdm3b Decreases Spermatogenesis and Impairs Male Sexual Behaviors
por: Liu, Zhaoliang, et al.
Publicado: (2015)

The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes
por: Trempenau, Mette Louise, et al.
Publicado: (2023)

The histone demethylase Kdm3a is essential to progression through differentiation
por: Herzog, Marielle, et al.
Publicado: (2012)

Elevated histone demethylase KDM5C increases recurrent miscarriage risk by preventing trophoblast proliferation and invasion
por: Xiao, Min, et al.
Publicado: (2022)

Friend or foe: role of E-cadherin in prostate cancer metastasis
por: Lin, Ching-Yu, et al.
Publicado: (2016)

New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer
por: Lin, Ching-Yu, et al.
Publicado: (2020)

How substrate specificity is imposed on a histone demethylase—lessons from KDM2A
por: Tsai, Chi-Lin, et al.
Publicado: (2014)

Activation of Xist by an evolutionarily conserved function of KDM5C demethylase
por: Samanta, Milan Kumar, et al.
Publicado: (2022)

ETS transcription factor ERG cooperates with histone demethylase KDM4A
por: KIM, TAE-DONG, et al.
Publicado: (2016)

Targeting Histone Demethylase LSD1/KDM1a in Neurodegenerative Diseases
por: Ambrosio, Susanna, et al.
Publicado: (2018)

Human histone demethylase KDM6B can catalyse sequential oxidations
por: Hopkinson, Richard J., et al.
Publicado: (2018)

KDM5 histone demethylases repress immune response via suppression of STING
por: Wu, Lizhen, et al.
Publicado: (2018)

The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer
por: Wilson, C, et al.
Publicado: (2017)

Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease
por: Mokou, Marika, et al.
Publicado: (2019)

Advances in Histone Demethylase KDM3A as a Cancer Therapeutic Target
por: Yoo, Jung, et al.
Publicado: (2020)

Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
por: Jose, Anmi, et al.
Publicado: (2020)

Structure‐Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases
por: Małecki, Piotr H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tarn6rj9ucbfpf8ohd5mbmm9mj